EFFICACY AND TOLERANCE OF DACARBAZINE OR TEMOZOLOMIDE CHEMOTHERAPY COMBINED OR NOT WITH 5-FU FOR ENDOCRINE CARCINOMAS: A RETROSPECTIVE MULTICENTER STUDY FROM THE GROUPE D’ETUDE DES TUMEURS ENDOCRINES (GTE)

(1) Gastroenterology, Hopital Robert Debre, Reims

(2) Endocrine Oncology, Institut Gustave Roussy, Villejuif

(3) Endocrinology, Hopital Robert Debre, Reims

(4) Gastroenterology, Hopital Haut Leveque, Bordeaux

(5) CRICAM, Hopital Robert Debre, Reims, France

(6) Gastroenterology, Hopital La Charite, Berlin, Germany



This item was part of the PANCREAS I session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A242